Cancer Podcasts from Dana-Farber: Recent Episodes
Dana-Farber Cancer Institute
Treatment ends. And you’re home free. That’s what many friends and family think. But cancer patients know that the time after your treatment ends can be unsettling. While the physical and logistical challenges of managing chemotherapy, radiation or surgery may be behind you, the prospect of dealing with cancer without the safety net of weekly, ... Read more
The post Beyond Cancer Podcast – Episode #6: When Treatment Ends appeared first on Dana-Farber Cancer Institute.
Stupid things. We all say them. And cancer patients have heard them all — from the insensitive to the absurd, from nutrition tips to fertility advice, and just about everything in between. While patients can laugh (hopefully) at the remarks in hindsight, when they’re first said, they can cut deep, making patients question their decisions. ... Read more
The post Beyond Cancer Podcast – Episode #5: Stupid Things People Say appeared first on Dana-Farber Cancer Institute.
Brain tumors can be among the most challenging cancers to treat. The blood-brain barrier, a natural defense mechanism that shields the brain from harm, can also prevent cancer treatments from reaching tumors. “It can be difficult to get treatments effectively into the brain,” says David Reardon, MD, clinical director of Dana-Farber’s Center for Neuro-Oncology. However, ... Read more
The post Cancer Conversations Podcast—Episode #17: The Latest in Brain Tumor Research and Treatment appeared first on Dana-Farber Cancer Institute.
Prostate cancer affects 230,000 men each year. Although diagnoses are increasing worldwide, most people die with prostate cancer and not of prostate cancer, according to Mark Pomerantz, MD, a medical oncologist in Dana-Farber’s Lank Center for Genitourinary Oncology. In this Cancer Conversations podcast episode, Pomerantz discusses genetics, risk factors, and the controversy surrounding the PSA ... Read more
The post Cancer Conversations Podcast—Episode #16: The Latest in Prostate Cancer Treatment and Research appeared first on Dana-Farber Cancer Institute.
Lung cancer is the second most common cancer in men and women, but lung cancer research is advancing rapidly and treatments are improving at an astonishing pace. “Lung cancer research has changed so much today that it’s even hard to estimate what we’re going to be doing in the future,” says Geoffrey Oxnard, MD, of ... Read more
The post Cancer Conversations Podcast – Episode #15: What You Need to Know About Lung Cancer Treatment and Research appeared first on Dana-Farber Cancer Institute.
If you’re 69 and diagnosed with pancreatic cancer, what do you do? For John Barrett, the answer was easy: become a certified physical trainer. But as Barrett and Nancy Campbell, exercise physiologist at Dana-Farber, both point out, you don’t need to be an exercise zealot to incorporate exercise into your life. “Exercise needs to be ... Read more
The post Beyond Cancer Podcast – Episode #4: Exercise and Cancer appeared first on Dana-Farber Cancer Institute.
It was a warm day in November 2013 when Gabby Spear found out she had breast cancer. But even in the midst of the difficult news, her responsibilities as a mom, wife, professional, and community member remained; she knew she still had to pick up her two daughters and make it to temple service later ... Read more
The post Voices Podcast – Episode #5: Balancing Motherhood and Breast Cancer appeared first on Dana-Farber Cancer Institute.
Advances in genetic research may improve the prevention, diagnosis, and treatment of women’s cancers. “More genes are being found and fewer families are having to wonder if there is something genetic that may increase their risk, or future generations’ risk, of developing cancer,” says Judy Garber, MD, MPH, director of the Center for Cancer Genetics ... Read more
The post Cancer Conversations Podcast—Episode #14—The Latest in Genetics and Women’s Cancers appeared first on Dana-Farber Cancer Institute.